Literature DB >> 22766738

Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.

Diego Sepulveda-Falla1, Markus Glatzel, Francisco Lopera.   

Abstract

Presenilin 1 (PS1) mutations are the most common cause of early-onset familial Alzheimer's disease (EOFAD). They show a common phenotypic profile characterized by early age of onset, severe dementia and distinct neurodegeneration. The largest population of EOFAD carries the E280A mutation in PS1 and resides in Antioquia, Colombia, currently comprising around 5,000 individuals. Carriers start showing memory impairment in the third decade of life, followed by progressive impairment of language and other cognitive processes. They reach mild cognitive impairment around 45 and dementia around 50 years of age. There is some phenotypic variability among the carriers of this single PS1 mutation. Some patients present with epilepsy, verbal impairment, and cerebellar ataxia. Neuropathologically, PS1 E280A cases show pronounced brain atrophy, severe amyloid-β pathology, distinct hyperphosphorylated tau-related pathology, and cerebellar damage. The earliest event identified by functional magnetic imaging resonance is hyperactivation within the right anterior hippocampus around 33 years of age. This well-studied population with a clear pre-clinical profile and wide phenotypic variability in age of onset and clinical presentation is ideally suited for clinical trials and to study molecular mechanisms of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766738     DOI: 10.3233/JAD-2012-120907

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

1.  A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease.

Authors:  Natalia Dolzhanskaya; Michael A Gonzalez; Fiorella Sperziani; Shannon Stefl; Jeffrey Messing; Guang Y Wen; Emil Alexov; Stephan Zuchner; Milen Velinov
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Neuronal Network Excitability in Alzheimer's Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau.

Authors:  Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira
Journal:  eNeuro       Date:  2021-04-23

3.  Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Paulo Victor Sgobbi de Souza; Paulo Henrique Ferreira Bertolucci; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

4.  Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Authors:  Diego Sepulveda-Falla; Alvaro Barrera-Ocampo; Christian Hagel; Anne Korwitz; Maria Fernanda Vinueza-Veloz; Kuikui Zhou; Martijn Schonewille; Haibo Zhou; Luis Velazquez-Perez; Roberto Rodriguez-Labrada; Andres Villegas; Isidro Ferrer; Francisco Lopera; Thomas Langer; Chris I De Zeeuw; Markus Glatzel
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 5.  Is there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programs.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2014-09-19       Impact factor: 5.590

Review 6.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

7.  Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred.

Authors:  J T Fuller; A Cronin-Golomb; J R Gatchel; D J Norton; E Guzmán-Vélez; H I L Jacobs; B Hanseeuw; E Pardilla-Delgado; A Artola; A Baena; Y Bocanegra; K S Kosik; K Chen; P N Tariot; K Johnson; R A Sperling; E M Reiman; F Lopera; Y T Quiroz
Journal:  J Prev Alzheimers Dis       Date:  2019

8.  Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.

Authors:  Viviana Soto-Mercado; Miguel Mendivil-Perez; Carlos Velez-Pardo; Francisco Lopera; Marlene Jimenez-Del-Rio
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

9.  Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.

Authors:  Viviana Soto-Mercado; Miguel Mendivil-Perez; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.

Authors:  Jorge J Llibre-Guerra; Yan Li; Ricardo F Allegri; Patricio Chrem Mendez; Ezequiel I Surace; Juan J Llibre-Rodriguez; Ana Luisa Sosa; Carmen Aláez-Verson; Erika-Mariana Longoria; Alberto Tellez; Karol Carrillo-Sánchez; Luis Leonardo Flores-Lagunes; Victor Sánchez; Leonel Tadao Takada; Ricardo Nitrini; Norberto Anizio Ferreira-Frota; Joyce Benevides-Lima; Francisco Lopera; Laura Ramírez; Ivonne Jiménez-Velázquez; Christian Schenk; Daisy Acosta; María Isabel Behrens; Michelle Doering; Ellen Ziegemeier; John C Morris; Eric McDade; Randall J Bateman
Journal:  Alzheimers Dement       Date:  2020-11-23       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.